Login
Search
Search
0 Dates
2024
2023
2022
2021
2020
2019
2018
0 Events
CPC 2018
CPC 2019
Curso de Atualização em Medicina Cardiovascular 2019
Reunião Anual Conjunta dos Grupos de Estudo de Cirurgia Cardíaca, Doenças Valvulares e Ecocardiografia da SPC
CPC 2020
CPC 2021
CPC 2022
CPC 2023
CPC 2024
0 Topics
A. Basics
B. Imaging
C. Arrhythmias and Device Therapy
D. Heart Failure
E. Coronary Artery Disease, Acute Coronary Syndromes, Acute Cardiac Care
F. Valvular, Myocardial, Pericardial, Pulmonary, Congenital Heart Disease
G. Aortic Disease, Peripheral Vascular Disease, Stroke
H. Interventional Cardiology and Cardiovascular Surgery
I. Hypertension
J. Preventive Cardiology
K. Cardiovascular Disease In Special Populations
L. Cardiovascular Pharmacology
M. Cardiovascular Nursing
N. E-Cardiology / Digital Health, Public Health, Health Economics, Research Methodology
O. Basic Science
P. Other
0 Themes
01. History of Cardiology
02. Clinical Skills
03. Imaging
04. Arrhythmias, General
05. Atrial Fibrillation
06. Supraventricular Tachycardia (non-AF)
07. Syncope and Bradycardia
08. Ventricular Arrhythmias and Sudden Cardiac Death (SCD)
09. Device Therapy
10. Chronic Heart Failure
11. Acute Heart Failure
12. Coronary Artery Disease (Chronic)
13. Acute Coronary Syndromes
14. Acute Cardiac Care
15. Valvular Heart Disease
16. Infective Endocarditis
17. Myocardial Disease
18. Pericardial Disease
19. Tumors of the Heart
20. Congenital Heart Disease and Pediatric Cardiology
21. Pulmonary Circulation, Pulmonary Embolism, Right Heart Failure
22. Aortic Disease
23. Peripheral Vascular and Cerebrovascular Disease
24. Stroke
25. Interventional Cardiology
26. Cardiovascular Surgery
27. Hypertension
28. Risk Factors and Prevention
29. Rehabilitation and Sports Cardiology
30. Cardiovascular Disease in Special Populations
31. Pharmacology and Pharmacotherapy
32. Cardiovascular Nursing
33. e-Cardiology / Digital Health
34. Public Health and Health Economics
35. Research Methodology
36. Basic Science
37. Miscellanea
0 Resources
Abstract
Slides
Vídeo
Report
CLEAR FILTERS
Long-term performance of leadless pacemaker: results from a multicentre registry
Session:
Sessão de Comunicações Orais - Dispositivos Médicos
Speaker:
João Carmo
Congress:
CPC 2020
Topic:
C. Arrhythmias and Device Therapy
Theme:
09. Device Therapy
Subtheme:
09.1 Antibradycardia Pacing
Session Type:
Comunicações Orais
FP Number:
---
Authors:
João Carmo; Diogo Cavaco; Fabio Klemz; Pedro Lopes Do Carmo; Francisco Moscoso Costa; Gustavo Da Rocha Rodrigues; José Alencar; Maria Salomé Carvalho; Daniel Nascimento Matos; Francisco Bello Morgado; Pedro Adragão; Miguel Mendes
Abstract
<p>Background: The leadless has emerged as an alternative to conventional pacing. First studies showed a high implantation success rate and a low complication rate. The long-term performance of these devices remains uncertain.</p> <p>Objectives: To evaluate the safety and electrical performance at long-term follow-up of the Micra™ leadless pacemaker (MLP). </p> <p>Methods: Prospective registry from two centres that included 97 consecutive patients who were implanted with a MLP between June 2015 and December 2018. The safety and efficacy of the device were assessed. </p> <p>Results: The cohort had a mean age of 77±11 years old and 36% were female. The indications for pacing were atrial fibrillation with atrioventricular node (AV) disease (71%), complete AV block (19%) and sinus node disease (10%). Micra was implanted with success in all patients. During the first 30 days, complications were low (3%): one femoral pseudo-aneurysm needing surgical treatment, one pericardial effusion without need for drainage and one conventional pacemaker implantation in the following day because of loss of ventricular capture. Two patients died in the first 30 days after implantation but it was unrelated to the procedure or device. The electrical performance was excellent at implantation and long-term follow-up (mean 26 months). The mortality at the end of follow-up was 24%. </p> <p>Conclusions: Long-term performance of the Micra pacemaker remains consistent with previously reported data and complications were low.</p>
Our mission: To reduce the burden of cardiovascular disease
Visit our site
